López, Frank A.

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

Connor, D. F., Findling, R. L., Kollins, S. H., Sallee, F., López, F. A., Lyne, A., & Tremblay, G. (2010) · CNS Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 101

Varying the Wear Time of the Methylphenidate Transdermal System in Children With Attention-Deficit/Hyperactivity Disorder

WILENS, T. E., BOELLNER, S. W., LÓPEZ, F. A., TURNBOW, J. M., WIGAL, S. B., CHILDRESS, A. C., ABIKOFF, H. B., & MANOS, M. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 58

Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder

Kollins, S. H., López, F. A., Vince, B. D., Turnbow, J. M., Farrand, K., Lyne, A., Wigal, S. B., & Roth, T. (2011) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 53

Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder

Pliszka, S. R., Wilens, T. E., Bostrom, S., Arnold, V. K., Marraffino, A., Cutler, A. J., López, F. A., DeSousa, N. J., Sallee, F. R., Incledon, B., et al. (2017) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 44

Guanfacine Extended Release: A Novel Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

Faraone, S. V., McBurnett, K., Sallee, F. R., Steeber, J., & López, F. A. (2013) · Clinical Therapeutics

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 44

Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges

López, F. A., & Leroux, J. R. (2013) · ADHD Attention Deficit and Hyperactivity Disorders

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 43

Duration of effect of oral long-acting stimulant medications for ADHD throughout the day

Brams, M., Moon, E., Pucci, M., & López, F. A. (2010) · Current Medical Research and Opinion

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 30

Changes in Emotions Related to Medication Used to Treat ADHD. Part I: Literature Review

Manos, M. J., Brams, M., Childress, A. C., Findling, R. L., López, F. A., & Jensen, P. S. (2011) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 28

ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years

López, F. A., Childress, A., Adeyi, B., Dirks, B., Babcock, T., Scheckner, B., Lasser, R. A., Shepski, J., & Arnold, V. (2017) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 11

Assessing Effects of Treatment With Lisdexamfetamine Dimesylate for Pediatric ADHD Using a Parental Survey

Antonucci, D., Kunins, C., Manos, M., López, F. A., & Kerney, D. L. (2010) · CNS Spectrums

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 6

A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release Methylphenidate in Children Aged 6 to 12 Years of Age Participating in Two Phase 3 Clinical Trials

Arnold, V. K., López, F. A., Childress, A. C., Po, M. D., Uchida, C. L., Cuthbertson, L., Sallee, F. R., & Incledon, B. (2024) · Journal of Attention Disorders

Attention Deficit Hyperactivity DisorderChild and Adolescent Psychosocial and Emotional Development

Cited by 1